Cargando…
Analysis of 116 cases of rectal cancer treated by transanal local excision
BACKGROUND: The purpose of this research was to evaluate the therapeutic effects and prognostic factors of transanal local excision (TAE) for rectal cancer. METHODS: We retrospectively analyzed 116 cases that underwent TAE for rectal cancer from 1995 to 2008. A Cox regression analysis was used to an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123824/ https://www.ncbi.nlm.nih.gov/pubmed/25008129 http://dx.doi.org/10.1186/1477-7819-12-202 |
_version_ | 1782329533310959616 |
---|---|
author | Sun, Gongping Tang, Yuanxin Li, Xiaoxia Meng, Jin Liang, Gaofeng |
author_facet | Sun, Gongping Tang, Yuanxin Li, Xiaoxia Meng, Jin Liang, Gaofeng |
author_sort | Sun, Gongping |
collection | PubMed |
description | BACKGROUND: The purpose of this research was to evaluate the therapeutic effects and prognostic factors of transanal local excision (TAE) for rectal cancer. METHODS: We retrospectively analyzed 116 cases that underwent TAE for rectal cancer from 1995 to 2008. A Cox regression analysis was used to analyze prognostic factors. RESULTS: The survival times for the patients were from 14 to 160.5 months (median time, 58.5 months). The 5-year and 10-year overall survival rates were 72% and 53%, respectively. In all 16 cases experienced local recurrence (13.8%). Pathological type, recurrence or metastasis, and depth of infiltration (T stage) were the prognostic factors according to the univariate analysis, and the latter two were independent factors affecting patient prognosis. For patients with T1 stage who underwent adjuvant radiotherapy, there was no local recurrence; for those in T2 stage, the local recurrence rate was 14.6%. In addition, there was no difference between the patients who received radiotherapy and those who did not (T1: P = 0.260, T2: P = 0.262 for survival rate and T1: P = 0.480, T2: P = 0.560 for recurrence). CONCLUSIONS: The result of TAE for rectal cancer is satisfactory for T1 stage tumors, but it is not suitable for T2 stage tumors. |
format | Online Article Text |
id | pubmed-4123824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41238242014-08-07 Analysis of 116 cases of rectal cancer treated by transanal local excision Sun, Gongping Tang, Yuanxin Li, Xiaoxia Meng, Jin Liang, Gaofeng World J Surg Oncol Research BACKGROUND: The purpose of this research was to evaluate the therapeutic effects and prognostic factors of transanal local excision (TAE) for rectal cancer. METHODS: We retrospectively analyzed 116 cases that underwent TAE for rectal cancer from 1995 to 2008. A Cox regression analysis was used to analyze prognostic factors. RESULTS: The survival times for the patients were from 14 to 160.5 months (median time, 58.5 months). The 5-year and 10-year overall survival rates were 72% and 53%, respectively. In all 16 cases experienced local recurrence (13.8%). Pathological type, recurrence or metastasis, and depth of infiltration (T stage) were the prognostic factors according to the univariate analysis, and the latter two were independent factors affecting patient prognosis. For patients with T1 stage who underwent adjuvant radiotherapy, there was no local recurrence; for those in T2 stage, the local recurrence rate was 14.6%. In addition, there was no difference between the patients who received radiotherapy and those who did not (T1: P = 0.260, T2: P = 0.262 for survival rate and T1: P = 0.480, T2: P = 0.560 for recurrence). CONCLUSIONS: The result of TAE for rectal cancer is satisfactory for T1 stage tumors, but it is not suitable for T2 stage tumors. BioMed Central 2014-07-09 /pmc/articles/PMC4123824/ /pubmed/25008129 http://dx.doi.org/10.1186/1477-7819-12-202 Text en Copyright © 2014 Sun et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Sun, Gongping Tang, Yuanxin Li, Xiaoxia Meng, Jin Liang, Gaofeng Analysis of 116 cases of rectal cancer treated by transanal local excision |
title | Analysis of 116 cases of rectal cancer treated by transanal local excision |
title_full | Analysis of 116 cases of rectal cancer treated by transanal local excision |
title_fullStr | Analysis of 116 cases of rectal cancer treated by transanal local excision |
title_full_unstemmed | Analysis of 116 cases of rectal cancer treated by transanal local excision |
title_short | Analysis of 116 cases of rectal cancer treated by transanal local excision |
title_sort | analysis of 116 cases of rectal cancer treated by transanal local excision |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123824/ https://www.ncbi.nlm.nih.gov/pubmed/25008129 http://dx.doi.org/10.1186/1477-7819-12-202 |
work_keys_str_mv | AT sungongping analysisof116casesofrectalcancertreatedbytransanallocalexcision AT tangyuanxin analysisof116casesofrectalcancertreatedbytransanallocalexcision AT lixiaoxia analysisof116casesofrectalcancertreatedbytransanallocalexcision AT mengjin analysisof116casesofrectalcancertreatedbytransanallocalexcision AT lianggaofeng analysisof116casesofrectalcancertreatedbytransanallocalexcision |